Table 1 Clinical information for gastric cancer patients and normal controls analyzed by 1H NMR
From: Tissue metabolic profiling of human gastric cancer assessed by 1H NMR
| Â | Gastricl cancer patients | Normal controls |
|---|---|---|
Number | 125 | 54 |
Age (median, range) | 60 28–86 | 61 28–80 |
Male/female ration | 91/34 | 39/15 |
Histology | Adenocarcinoma (120) | ∕ |
| Â | NA (5) | Â |
Pathologic grade |  | ∕ |
 PD | 74 |  |
 MD | 46 |  |
 WD | 0 |  |
 NA | 5 |  |
Cancer stage/Duke |  | ∕ |
 I/A (30) | T1N0M0 (7) |  |
| Â | T1N1M0 (4) | Â |
| Â | T2N0M0 (19) | Â |
 II/B (46) | T2N1M0 (5) |  |
| Â | T3N0M0 (15) | Â |
| Â | T2N2M0 (1) | Â |
| Â | T3N1M0 (12) | Â |
| Â | T4aN0M0 (13) | Â |
 III/C (37) | T2N3M0 (3) |  |
| Â | T3N2M0 (10) | Â |
| Â | T4aN1M0 (8) | Â |
| Â | T4aN2M0 (9) | Â |
| Â | T4aN3aM0 (1) | Â |
| Â | T4bN1M0 (4) | Â |
| Â | T4bN2M0 (2) | Â |
 IV/D (12) | T2N1M1 (1) |  |
| Â | T3N1M1 (1) | Â |
| Â | T3N2M1 (4) | Â |
| Â | T3N3aM1 (2) | Â |
| Â | T4aN3aM1 (4) | Â |